ROBERT SHULMAN to Anti-Bacterial Agents
This is a "connection" page, showing publications ROBERT SHULMAN has written about Anti-Bacterial Agents.
Connection Strength
0.113
-
Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014 May; 146(6):1500-12.
Score: 0.047
-
A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. Am J Gastroenterol. 2009 Sep; 104(9):2326-33.
Score: 0.034
-
Reducing broad-spectrum antibiotic use in intensive care unit between first and second waves of COVID-19 did not adversely affect mortality. J Hosp Infect. 2022 Jun; 124:37-46.
Score: 0.020
-
Selective decontamination of the digestive tract in critically ill patients treated in intensive care units: a mixed-methods feasibility study (the SuDDICU study). Health Technol Assess. 2014 Apr; 18(25):1-170.
Score: 0.012